MEDIPOST Financials
| 078160 Stock | KRW 12,350 380.00 3.17% |
MEDIPOST |
Understanding current and past MEDIPOST Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of MEDIPOST's financial statements are interrelated, with each one affecting the others. For example, an increase in MEDIPOST's assets may result in an increase in income on the income statement.
Please note, the presentation of MEDIPOST's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MEDIPOST's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MEDIPOST's management manipulating its earnings.
MEDIPOST Stock Summary
MEDIPOST competes with Korea Information, Wireless Power, LG Household, Lotte Data, and CKH Food. MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. MEDIPOST Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea. MEDIPOST is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7078160009 |
| Business Address | 21 Daewangpangyo ro |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.medi-post.co.kr |
| Phone | (82) 2 3465 6688 |
| Currency | KRW - South Korean Won |
You should never invest in MEDIPOST without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of MEDIPOST Stock, because this is throwing your money away. Analyzing the key information contained in MEDIPOST's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
MEDIPOST Key Financial Ratios
MEDIPOST's financial ratios allow both analysts and investors to convert raw data from MEDIPOST's financial statements into concise, actionable information that can be used to evaluate the performance of MEDIPOST over time and compare it to other companies across industries.| Return On Equity | 1.87 | |||
| Return On Asset | -0.0113 | |||
| Target Price | 122700.0 | |||
| Number Of Employees | 267 | |||
| Beta | 1.0 |
MEDIPOST Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MEDIPOST's current stock value. Our valuation model uses many indicators to compare MEDIPOST value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MEDIPOST competition to find correlations between indicators driving MEDIPOST's intrinsic value. More Info.MEDIPOST Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value MEDIPOST by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MEDIPOST's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.MEDIPOST Systematic Risk
MEDIPOST's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MEDIPOST volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on MEDIPOST correlated with the market. If Beta is less than 0 MEDIPOST generally moves in the opposite direction as compared to the market. If MEDIPOST Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MEDIPOST is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MEDIPOST is generally in the same direction as the market. If Beta > 1 MEDIPOST moves generally in the same direction as, but more than the movement of the benchmark.
MEDIPOST December 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MEDIPOST help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MEDIPOST Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of MEDIPOST Co based on widely used predictive technical indicators. In general, we focus on analyzing MEDIPOST Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MEDIPOST's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.1 | |||
| Information Ratio | 0.2085 | |||
| Maximum Drawdown | 26.54 | |||
| Value At Risk | (7.80) | |||
| Potential Upside | 14.36 |
Complementary Tools for MEDIPOST Stock analysis
When running MEDIPOST's price analysis, check to measure MEDIPOST's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIPOST is operating at the current time. Most of MEDIPOST's value examination focuses on studying past and present price action to predict the probability of MEDIPOST's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIPOST's price. Additionally, you may evaluate how the addition of MEDIPOST to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |